Subscribe to the DGH Digest

Get the latest news from the Department of Global Health in the latest DGH Digest, available for viewing and downloading here.

The July edition features stories about new forms of HIV prevention and tuberculosis testing, photos from the IAS Conference in Mexico City, and news about new hires within the department.

To subscribe to all DGH newsletters and ensure that you don't miss any news, events, and/or opportunities, click here.

UW Students, Faculty Showcase Cutting-Edge Research at World’s Most Influential Meeting On HIV

More than 5,900 HIV professionals from nearly 130 countries participated in the recent International AIDS Society Conference on HIV Science (IAS), including a strong UW showing that included Department of Global Health students, faculty and alumni who presented groundbreaking new research impacting HIV/AIDS treatment and prevention. 

The conference, where participants presented critical advances in basic, clinical and operational research that move science into policy and practice, took place in Mexico City, Mexico, on 21-24 July 2019.

Global Health Professor Receives Grant to Strengthen Research Training Consortium

The John E. Fogarty International Center and National Institutes of Health (NIH) have awarded a $900,000 grant to University of Washington global health professor Joseph Zunt. The grant will strengthen the Northern Pacific Global Health Research Training Consortium Program, which trains doctoral and post-doctoral fellows in the health profession. 

Judd Walson Named Department of Global Health Vice Chair

Dr. Judd Walson, MD, MPH, has been named Vice Chair of the Department of Global Health, effective August 1, 2019. 

Walson is a professor of Global Health, Medicine, and Pediatrics, as well as an Adjunct Professor of Epidemiology. In addition, Walson is also the Principal Investigator of the DeWorm3 Project, which focuses on finding ways to eliminate soil-transmitted helminths, known commonly as intestinal worms. 

PrEP Use High but Wanes after Three Months Among Young African Women

In a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months. However, PrEP use fell among participants in this critical population during a year of follow-up clinic visits, although HIV incidence at 12 months was low. The preliminary results suggest that tailored, evidence-based adherence support strategies may be needed to durably engage young African women in consistent PrEP use. 

Most Women Use Vaginal Ring for HIV Prevention in Open-Label Study

In an open-label study of women in southern and eastern Africa, a vaginal ring that is inserted once a month and slowly releases an antiviral drug was estimated to reduce the risk of HIV by 39%, according to statistical modeling. In addition, the study found that participants appeared to use the ring more in the open-label study than in a previous clinical trial. These and other results of the HIV Open Label Extension (HOPE) study were presented today at the 10th IAS Conference on HIV Science (IAS 2019) in Mexico City.

Faculty Profile: Susan Graham - Associate Professor, Global Health and Medicine

In late-May of 2019, Kenya’s high court voted to uphold laws criminalizing homosexual sex. This news was pertinent to Susan Graham, an Associate Professor in the UW Departments of Global Health and Medicine whose research focus is on HIV prevention and care for vulnerable populations. Graham began working in Kenya in 2004, and started research on HIV prevention and care for gay, bisexual, and other men who have sex with men (MSM) there in 2006. 

Pages